• Diagnosis​ Info ​and​ ​General​ ​Questions

  Adakveo, 1st Sickle Cell Treatment for Pain Crises in Teens and Adults, Approved by FDA

  Posted by Sickle Cell Forum Administrator on March 26, 2021 at 9:00 am

  

  Adakveo (crizanlizumab), which works to lower the frequency of painful vaso-occlusive crises (VOCs) common in sickle cell disease, has been approved by the FDA. Read the full story here.

  What do you think of this news?

  Sickle Cell Forum Administrator replied 4 years, 3 months ago 0 Member · 0 Replies

  • Diagnosis
  • Research
• 0 Replies

Log In to Reply